Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
40 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion. (NCT07184606) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2025-09-01 |
| "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients". (NCT07156864) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2025-09-01 |
| An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis" (NCT06815549) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2025-02-17 |
| Study of the Drug B11-FC (Botulism Treatment) (NCT06580236) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2024-08-01 |
| Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV (NCT06135350) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-11-06 |
| An Open-label Study of the Safety and Pharmacokinetics of the TGKP (NCT06127381) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-11-01 |
| Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition) (NCT06068556) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-10-01 |
| Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers (NCT06068569) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-10-01 |
| Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition. (NCT06057025) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-09-01 |
| The Surveillance Clinical Study of Rickettsiosis (NCT06162975) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-04-01 |
| Study of Monoclonal Antibodies for Early Etiotropic Therapy for Coronavirus Infection Caused by the SARS-CoV-2 Virus (NCT05729360) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2023-03-01 |
| HIV A6 Genome In ART Unsuccessful Patients On DOR (NCT05322083) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2022-05-01 |
| Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray (NCT05248373) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2022-03-08 |
| Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac (NCT04975737) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2022-01-20 |
| Study of Gam-COVID-Vac in Adolescents (NCT04954092) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-07-05 |
| Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light (NCT04741061) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-02-19 |
| An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease (NCT04717830) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-02-15 |
| An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine (NCT04713488) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2021-01-15 |
| A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE (NCT04656613) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-12-01 |
| Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela (NCT04642339) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-11-01 |
| The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older (NCT04587219) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-10-22 |
| Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus (NCT04564716) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-09-28 |
| Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 (NCT04530396) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-09-07 |
| An Open Study of the Safety, Tolerability and Immunogenicity of "Gam-COVID-Vac Lyo" Vaccine Against COVID-19 (NCT04437875) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-06-17 |
| An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19 (NCT04436471) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2020-06-17 |
| Study of Safety and Immunogenicity of BVRS-GamVac (NCT04130594) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-07 |
| Study of Safety and Immunogenicity of BVRS-GamVac-Combi (NCT04128059) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-11-06 |
| A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac (NCT04034290) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-10-18 |
| A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (NCT04036526) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-06-04 |
| Phase II Clinical Trial of Safety and Immunogenicity of Recombinant Subunit Tuberculosis Vaccine GamTBvac (NCT03878004) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-12-01 |
| Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa (NCT03638830) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-10-17 |
| The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac (NCT03651544) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-10-15 |
| An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola (NCT03428347) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-03-12 |
| A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo (NCT03333538) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-11-03 |
| An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers (NCT03205462) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-08-10 |
| International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi (NCT03072030) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-08-03 |
| A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (NCT03137927) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-06-13 |
| Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis. (NCT03255278) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-01-15 |
| Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi (NCT02911415) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2016-10-01 |
| Open Study of the Duration of Immunity After Vaccination With GamEvac (NCT02911428) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2016-10-01 |
Track Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation automatically
Every clearance here is in the API, with alerts when new ones post.